Latest filing published 14 Aug 2025 for IGM Biosciences, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Christina Teng Topsoe (board member) discloses dealings in IGM Biosciences, Inc. to SEC (Form 4). Over a trading history stretching from 30 June 2021 to 14 August 2025, the count stands at 18 filings.
No open-market sale appears; the market trades are 2 purchases worth €57k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 15 share grants.
On 14 August 2025 came the latest disclosure, a transaction in IGM Biosciences, Inc. The clock since the last published purchase (5 July 2023) now reads 1,201 days. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations